Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Daniel J Margolis
Affiliation
Weill Cornell Medical College
ORCID
Career Start Year
2003
Papers
169
H Index
42
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37973241
Interpretation of Prostate Magnetic Resonance Imaging Using Prostate Imaging and Data Reporting System Version 2.1: A Primer.
Radiol Clin North Am
2024
36334976
Pulse Sequence Dependence of a Simple and Interpretable Deep Learning Method for Detection of Clinically Significant Prostate Cancer Using Multiparametric MRI.
Acad Radiol
2023
37877601
Management of Patients With a Negative Multiparametric Prostate MRI Examination: <i>AJR</i> Expert Panel Narrative Review.
AJR Am J Roentgenol
2023
37441341
Partial-gland Cryoablation Outcomes for Localized Prostate Cancer in Patients with Magnetic Resonance Imaging (MRI)-visible and MRI-invisible Lesions.
Eur Urol Open Sci
2023
37004362
Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition.
Eur J Radiol
2023
37068148
The role of quantitative MRI-based prostate zonal parameters in predicting clinically significant prostate cancer A U.S. cohort.
Can Urol Assoc J
2023
33439577
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society.
Minerva Urol Nephrol
2022
34985786
Pilot study of the diagnostic utility of <sup>89</sup> Zr-df-IAB2M and <sup>68</sup> Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer.
Prostate
2022
35234995
Predictors of biliary intervention in patients hospitalized for COVID-19.
Abdom Radiol (NY)
2022
34672937
A prostate cancer risk calculator: Use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men.
Can Urol Assoc J
2022
34649151
68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study.
Transl Oncol
2022
32812795
PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative Review.
AJR Am J Roentgenol
2021
35755405
Three-dimensional prostate CT segmentation through fine-tuning of a pre-trained neural network using no reference labeling.
Proc SPIE Int Soc Opt Eng
2021
33876838
Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI.
Prostate
2021
33566638
Practice Patterns and Challenges of Performing and Interpreting Prostate MRI: A Survey by the Society of Abdominal Radiology Prostate Disease-Focused Panel.
AJR Am J Roentgenol
2021
33582104
Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy.
Eur Urol Oncol
2021
34591333
Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI.
Prostate
2021
34559112
Predictors of acute deep venous thrombosis in patients hospitalized for COVID-19.
Medicine (Baltimore)
2021
34161136
Increasing Utilization of MRI Before Prostate Biopsy in Black and Non-Black Men: An Analysis of the SEER-Medicare Cohort.
AJR Am J Roentgenol
2021
34217762
Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation.
Urology
2021
34071842
International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer.
Cancers (Basel)
2021
34292363
Prostate heterogeneity correlates with clinical features on multiparametric MRI.
Abdom Radiol (NY)
2021
33982018
Racial Variation in Membranous Urethral Length and Postprostatectomy Urinary Function.
Eur Urol Open Sci
2021
34254850
Pulmonary Embolism in Hospitalized Patients with COVID-19: A Multicenter Study.
Radiology
2021
33970516
Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
J Magn Reson Imaging
2021
33098478
Multivariate analysis of CT imaging, laboratory, and demographical features for prediction of acute kidney injury in COVID-19 patients: a Bi-centric analysis.
Abdom Radiol (NY)
2021
32755211
Commentary on "MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis".
AJR Am J Roentgenol
2021
31568795
Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy.
Urology
2020
31789578
Reply by Authors.
J Urol
2020
31784778
Utility of dynamic MRA in the evaluation of male erectile dysfunction.
Abdom Radiol (NY)
2020
31644434
Developments in MRI-targeted prostate biopsy.
Curr Opin Urol
2020
31642740
Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.
J Urol
2020
31954170
Prostate Multiparametric Magnetic Resonance Imaging Features Following Partial Gland Cryoablation.
Urology
2020
31797025
Prostate MRI with PI-RADS v2.1: initial detection and active surveillance.
Abdom Radiol (NY)
2020
32755355
Multicenter Multireader Evaluation of an Artificial Intelligence-Based Attention Mapping System for the Detection of Prostate Cancer With Multiparametric MRI.
AJR Am J Roentgenol
2020
32185445
PI-RADS: what is new and how to use it.
Abdom Radiol (NY)
2020
32307327
Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesions.
Urol Oncol
2020
32130048
Influence of the Location and Zone of Tumor in Prostate Cancer Detection and Localization on 3-T Multiparametric MRI Based on PI-RADS Version 2.
AJR Am J Roentgenol
2020
32315265
Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.
Radiology
2020
31502942
Variation in Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Outcomes in Asian American Men: A Multicenter Study.
J Urol
2020
31378664
Corrigendum to 'The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy' [European Urology Oncology 1 (2018) 263-267].
Eur Urol Oncol
2020
31492650
Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis.
Eur Urol Oncol
2020
29705281
A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
Acad Radiol
2019
35047782
IDEAL Stage 2a experience with in-office, transperineal MRI/ultrasound software fusion targeted prostate biopsy.
BMJ Surg Interv Health Technol
2019
35047774
Race and prostate imaging: implications for targeted biopsy and image-based prostate cancer interventions.
BMJ Surg Interv Health Technol
2019
31184561
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.
Radiology
2019
31587097
Annual short report of the society of abdominal radiology prostate cancer disease-focused panel.
Abdom Radiol (NY)
2019
31361529
Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
AJR Am J Roentgenol
2019
30898406
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.
Eur Urol
2019
31017088
The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy.
Eur Urol Oncol
2019
1 - 50 of 169
Column Actions
Search
Recommended Authors
Jeremie Calais
university of california los angeles
Career Start Year
2014
Number of shared co-authors
18
Neil Mendhiratta
National Cancer Institute, National Institutes of Health
Career Start Year
2013
Number of shared co-authors
13
Francesco Pellegrino
Urological Research Institute, IRCCS San Raffaele Hospital
Career Start Year
2012
Number of shared co-authors
4
Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year
2010
Number of shared co-authors
4
Ting Martin Ma
University of Washington
Career Start Year
2010
Number of shared co-authors
11
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year
2008
Number of shared co-authors
1
Aydin Pooli
David Geffen School of Medicine, University of California los angeles
Career Start Year
2008
Number of shared co-authors
14
Spencer C Behr
University of California san francisco
Career Start Year
2007
Number of shared co-authors
3
Thomas A Hope
University of California san francisco
Career Start Year
2007
Number of shared co-authors
9
Alastair D Lamb
University of Oxford
Career Start Year
2007
Number of shared co-authors
1
Nina Tunariu
The Institute of Cancer Research
Career Start Year
2005
Number of shared co-authors
5
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year
2005
Number of shared co-authors
8
Iva Petkovska
Memorial Sloan Kettering Cancer Center
Career Start Year
2004
Number of shared co-authors
3
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year
2004
Number of shared co-authors
13
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Career Start Year
2004
Number of shared co-authors
12
Ashley E Ross
Northwestern University
Career Start Year
2003
Number of shared co-authors
12
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year
2002
Number of shared co-authors
1
Tobias Maurer
Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Career Start Year
2002
Number of shared co-authors
5
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year
2001
Number of shared co-authors
3
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
2000
Number of shared co-authors
0
Vincent J Gnanapragasam
University of Cambridge
Career Start Year
1999
Number of shared co-authors
3
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Career Start Year
1998
Number of shared co-authors
4
Todd M Morgan
University of Michigan ann arbor
Career Start Year
1997
Number of shared co-authors
16
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1997
Number of shared co-authors
4
Brian J Davis
Mayo Clinic
Career Start Year
1997
Number of shared co-authors
10
Alan Thompson
The Royal Marsden NHS Foundation Trust
Career Start Year
1996
Number of shared co-authors
1
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Career Start Year
1996
Number of shared co-authors
5
Mark Frydenberg
Monash University
Career Start Year
1988
Number of shared co-authors
7
Damien Bolton
University of Melbourne
Career Start Year
1988
Number of shared co-authors
0
Marcelino Bernardo
Center for Interventional Oncology, National Institutes of Health
Career Start Year
1982
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Steven S Raman
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers
51
Jiaoti Huang
Duke University School of Medicine
Co-authored papers
32
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers
30
Jim C Hu
Weill Cornell Medical Center
Co-authored papers
22
Baris Turkbey
National Cancer Institute, National Institutes of Health
Co-authored papers
14
David S K Lu
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers
14
Masoom A Haider
University Health Network
Co-authored papers
11
Nelly Tan
Department of Radiology at the Mayo Clinic Hospital in Phoenix
Co-authored papers
11
Peter L Choyke
National Cancer Institute, National Institutes of Health
Co-authored papers
11
James Sayre
David Geffen School of Medicine at university of california los angeles
Co-authored papers
11
Ely R Felker
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers
9
Mitchell Kamrava
Cedars Sinai Medical Center
Co-authored papers
8
Timothy D McClure
Weill Cornell Medical College/New York Presbyterian
Co-authored papers
8
Pooria Khoshnoodi
University of Pittsburgh Medical Center
Co-authored papers
7
David S Karow
University of California San Diego School of Medicine
Co-authored papers
7
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Co-authored papers
7
Kyunghyun Sung
University of California los angeles
Co-authored papers
7
Joshua M Kuperman
University of California
Co-authored papers
6
John K Parsons
university of california san diego Moores Cancer Center
Co-authored papers
6
Anders M Dale
University of California San Diego
Co-authored papers
6
Hauke Bartsch
Haukeland University Hospital
Co-authored papers
6
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers
5
Michael A Liss
University of Texas Health San Antonio
Co-authored papers
5
Bradford J Wood
National Cancer Institute, National Institutes of Health
Co-authored papers
4
David Y Lu
Henry Ford Hospital
Co-authored papers
4
Anthony Sisk
University of California los angeles
Co-authored papers
4
Nazanin H Asvadi
Saint Vincent Hospital
Co-authored papers
4
William Hsu
American Medical Informatics Association, IEEE, Johns Hopkins University, Radiological Society of North America, University of California Los Angeles, University of California, Los Angeles
Co-authored papers
3
Pornphan Wibulpolprasert
Ramathibodi Hospital
Co-authored papers
3
William Hsu
Co-authored papers
3
1 - 30